Vertiginous epilepsy
A rare form of epilepsy triggered by visual stimuli
Vertiginous epilepsy is a rare form of epilepsy characterized by seizures that are triggered by specific visual stimuli, often involving motion or patterns that induce a sensation of vertigo. This condition is a subset of reflex epilepsy, where seizures are provoked by external stimuli.
Symptoms
The primary symptom of vertiginous epilepsy is the occurrence of seizures that are often preceded by a sensation of vertigo or dizziness. These seizures can vary in intensity and may include loss of consciousness, convulsions, or altered awareness. The vertiginous sensation is typically triggered by visual stimuli such as repetitive patterns, moving objects, or certain visual environments.
Causes
Vertiginous epilepsy is believed to be caused by abnormal electrical activity in the brain that is triggered by specific visual inputs. The exact mechanism is not fully understood, but it is thought to involve the visual cortex and areas of the brain responsible for processing motion and spatial orientation.
Diagnosis
Diagnosis of vertiginous epilepsy involves a combination of clinical evaluation, patient history, and diagnostic tests. Electroencephalography (EEG) is commonly used to detect abnormal brain activity associated with seizures. In some cases, magnetic resonance imaging (MRI) may be used to rule out other neurological conditions.
Treatment
Treatment for vertiginous epilepsy typically involves the use of antiepileptic drugs (AEDs) to control seizures. In some cases, avoiding known visual triggers can help manage the condition. Patients may also benefit from behavioral therapy to develop coping strategies for dealing with potential triggers.
Prognosis
The prognosis for individuals with vertiginous epilepsy varies. Some patients may achieve good seizure control with medication, while others may continue to experience seizures despite treatment. Avoidance of known triggers can significantly improve quality of life for affected individuals.
Related pages
References
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD